what is the most performance mid cap stock between october 1 2014 and december 30 2014

Xenon Pharmaceuticals (XENE) had the highest return between October 1, 2014 and December 30, 2014 by a mid-cap US stock, returning 97.5%.

ASSET DATE % RETURN
Xenon Pharmaceuticals (XENE)
10/1/2014 - 12/30/2014
97.5%
Cytokinetics (CYTK)
10/1/2014 - 12/30/2014
93.82%
ANI Pharmaceuticals (ANIP)
10/1/2014 - 12/30/2014
93.04%
Frontline (FRO)
10/1/2014 - 12/30/2014
87.68%
Agios Pharm (AGIO)
10/1/2014 - 12/30/2014
82.39%
SkyWest (SKYW)
10/1/2014 - 12/30/2014
66.82%
Applied Digital (APLD)
10/1/2014 - 12/30/2014
65.57%
Ionis Pharmaceuticals (IONS)
10/1/2014 - 12/30/2014
58.28%
American Airlines (AAL)
10/1/2014 - 12/30/2014
54.25%
Seaboard (SEB)
10/1/2014 - 12/30/2014
53.8%
Varonis Systems (VRNS)
10/1/2014 - 12/30/2014
52.12%
Amedisys (AMED)
10/1/2014 - 12/30/2014
49.6%
Ocular Therapeutix (OCUL)
10/1/2014 - 12/30/2014
48.57%
Merit Medical Systems (MMSI)
10/1/2014 - 12/30/2014
48.31%
TG Therapeutics (TGTX)
10/1/2014 - 12/30/2014
47.84%
Qorvo (QRVO)
10/1/2014 - 12/30/2014
46.67%
EXACT Sciences (EXAS)
10/1/2014 - 12/30/2014
46.61%
HNI (HNI)
10/1/2014 - 12/30/2014
45.76%
CarMax (KMX)
10/1/2014 - 12/30/2014
44.95%
MACOM Technology Solutions (MTSI)
10/1/2014 - 12/30/2014
43.61%
Chefs Warehouse (CHEF)
10/1/2014 - 12/30/2014
40.49%
Qualys (QLYS)
10/1/2014 - 12/30/2014
40.32%
HealthEquity (HQY)
10/1/2014 - 12/30/2014
40%
Matson (MATX)
10/1/2014 - 12/30/2014
39.94%
Magnite (MGNI)
10/1/2014 - 12/30/2014
38.96%
Mid-cap stocks are treated as having a market cap between $2B and $10B.